- |||||||||| F373280 / Pierre Fabre
Trial completion, Trial primary completion date: Efficacy and Safety Study of F373280 (clinicaltrials.gov) - Nov 24, 2017
P2, N=135, Completed,
Active, not recruiting --> Completed | Trial primary completion date: Sep 2017 --> Apr 2017
- |||||||||| F373280 / Pierre Fabre
Enrollment closed: Efficacy and Safety Study of F373280 (clinicaltrials.gov) - Nov 9, 2016
P2, N=135, Active, not recruiting,
Active, not recruiting --> Completed | Trial primary completion date: Sep 2017 --> Apr 2017 Terminated --> Active, not recruiting
- |||||||||| F373280 / Pierre Fabre
Trial termination: Efficacy and Safety Study of F373280 (clinicaltrials.gov) - Oct 21, 2016
P2, N=135, Terminated,
Terminated --> Active, not recruiting Recruiting --> Terminated
- |||||||||| F373280 / Pierre Fabre
Trial primary completion date: Efficacy and Safety Study of F373280 (clinicaltrials.gov) - Dec 4, 2015
P2, N=152, Recruiting,
Recruiting --> Terminated Trial primary completion date: Apr 2016 --> Jul 2017
- |||||||||| F373280 / Pierre Fabre
Trial primary completion date: Efficacy and Safety Study of F373280 (clinicaltrials.gov) - Sep 4, 2014
P2, N=152, Recruiting,
Trial primary completion date: Apr 2016 --> Jul 2017 Trial primary completion date: Jul 2014 --> Apr 2016
- |||||||||| F373280 / Pierre Fabre
Enrollment open: Efficacy and Safety Study of F373280 (clinicaltrials.gov) - Jun 3, 2013
P2, N=152, Recruiting,
Trial primary completion date: Jul 2014 --> Apr 2016 Not yet recruiting --> Recruiting
|
